🔗 Share this article TikTok Content Creators Fueling Unofficial Trade for Unlicensed Slimming Drug An underground market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, according to recent findings. Investigational Drug Acquiring Traction Via Social Media The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are urged to contact these accounts directly for supplier links, while also obtaining discount codes. Active Trade on Messaging Platforms Separately, a robust trade exists on Telegram, where groups with numerous of members share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting customers to WhatsApp for transactions. Learning About The Experimental Drug This medication is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic. Medical Experts Express Concerns However, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is a cause for concern and could lead to individuals injecting products of unknown origin. Some professionals stated the popularity for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro. Regulatory Status and Enforcement Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012. Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison. Platform Response and Material Removal Based on TikTok, the platform has taken down violative content and banned related keywords and query recommendations. The organization stated it was committed to keeping the platform secure and investing in enhancing enforcement strategies. Digital Marketplace Activities Investigations also found groups with up to nine thousand members selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of users, populated with images of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home. Within moments of entering one group, a vendor posted contact information, where most transactions occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about body mass, medical conditions or previous experience. Item Information and Costs Within these communities, messages show black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.” Buyers can select between powder vials, mixed at residence with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how much time a injector should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”. Service Moderation and Security Actions A representative for the messaging service stated it regularly monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”. Healthcare Expert Cautions “Individuals are injecting substances they cannot confirm. Even if the research behind this drug is valid, these digital versions may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service. Dr Crystal Wyllie of an online medical service connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained. Her staff has already seen patients injured by personal administration from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.” Manufacturer Position A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose users to possibly serious medical dangers”.